Related references
Note: Only part of the references are listed.Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of dual-genotype IDH-mutant infiltrating gliomas
Cinthya J. Zepeda-Mendoza et al.
ACTA NEUROPATHOLOGICA (2020)
Molecular Diagnostic of Solid Tumor Using a Next Generation Sequencing Custom-Designed Multi-Gene Panel
Dario de Biase et al.
DIAGNOSTICS (2020)
1p/19q co-deleted fibrillary astrocytomas: Not everything that is co-deleted is an oligodendroglioma
Cyril Andrews et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2020)
The role of clinical and molecular factors in low-grade gliomas: what is their impact on survival?
Enrico Franceschi et al.
FUTURE ONCOLOGY (2018)
Comparison of 1p and 19q status of glioblastoma by whole exome sequencing, array-comparative genomic hybridization, and fluorescence in situ hybridization
Jongmin Sim et al.
MEDICAL ONCOLOGY (2018)
Non-canonical IDH1 and IDH2 mutations: a clonal and relevant event in an Italian cohort of gliomas classified according to the 2016 World Health Organization (WHO) criteria
Michela Visani et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing 1p/19q Co-Deletion Analysis of Gliomas
Hendrikus J. Dubbink et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2016)
FISHing Tips: What Every Clinician Should Know About 1p19q Analysis in Gliomas Using Fluorescence in situ Hybridisation
M. B. Pinkham et al.
CLINICAL ONCOLOGY (2015)
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an integrated diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
David E. Reuss et al.
ACTA NEUROPATHOLOGICA (2015)
Chromogenic in situ Hybridization is a Reliable Alternative to Fluorescence in situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin-Embedded Gliomas
Ulrike Lass et al.
BRAIN PATHOLOGY (2013)
Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
Martin J. van den Bent et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
1p/19q testing has no significance in the workup of glioblastomas
K. H. Clark et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)
Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations
Xiao-Yang Liu et al.
ACTA NEUROPATHOLOGICA (2012)
The Importance of 10q Status in an Outcomes-Based Comparison Between 1p/19q Fluorescence In Situ Hybridization and Polymerase Chain Reaction-Based Microsatellite Loss of Heterozygosity Analysis of Oligodendrogliomas
Craig Horbinski et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS)
A. Woehrer et al.
CLINICAL NEUROPATHOLOGY (2011)
Detection of Allelic Status of 1p and 19q by Microsatellite-based PCR Versus FISH Limitations and Advantages in Application to Patient Management
Prerana Jha et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2011)
Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses
Artemis P. Vogazianou et al.
NEURO-ONCOLOGY (2010)
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: A prospective GICNO study
Alba A. Brandes et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment
Mathilde C. M. Kouwenhoven et al.
EUROPEAN JOURNAL OF CANCER (2006)
Fluorescence in situ hybridization (FISH) on touch preparations: A reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors
D Scheie et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Characterization of the 1p/19q chromosomal loss in oligodendrogliomas using comparative genomic hybridization arrays (CGHa)
JK Cowell et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas
JS Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
